logo
Alpha Modus, Corp. Takes Legal Action Against OptiSigns, Inc. for Patent Infringement

Alpha Modus, Corp. Takes Legal Action Against OptiSigns, Inc. for Patent Infringement

CORNELIUS, N.C., April 17, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) ('Company') announced today that its wholly owned subsidiary, Alpha Modus, Corp. ('Alpha Modus'), a leader in AI-driven retail technology, filed a patent infringement lawsuit against OptiSigns, Inc. The lawsuit, filed on April 15, 2025, in the United States District Court for the Southern District of Texas, alleges that OptiSigns has unlawfully utilized Alpha Modus's proprietary technologies without authorization.
The complaint asserts that OptiSigns's digital signage solutions infringe upon multiple patents held by Alpha Modus, including the '571, '825, '672, '890, and '880 patents. These patents encompass advanced retail marketing and advertising technologies designed to enhance consumer engagement at the point of decision. Alpha Modus's innovations enable real-time analysis of consumer behavior and product interaction, allowing businesses to dynamically adjust marketing strategies to meet immediate consumer needs.
William Alessi, CEO of Alpha Modus, stated, 'This legal action underscores our commitment to protecting our intellectual property and ensuring fair competition in the marketplace. Our patented technologies are at the forefront of transforming the retail experience, and we will take all necessary steps to safeguard our innovations. The investment community should expect to see more of the same—Alpha Modus will continue to file actions against both large and small retail and technology companies in the very near future and will continue to do so for as long as necessary. We believe this aggressive strategy will not only protect our assets but also drive significant long-term shareholder value.'
This lawsuit follows a series of similar actions taken by Alpha Modus to defend its intellectual property rights. In March 2025, Alpha Modus secured a landmark settlement with Shelf Nine LLC, while Shelf Nine's parent company, VSBLTY Groupe Technologies Corp., and Alpha Modus negotiate a strategic partnership for the deployment of Alpha Modus' cutting-edge technology which would include a perpetual license for Alpha Modus' patented innovations. Additionally, Alpha Modus has previously filed patent infringement lawsuits against major retailers such as Kroger, Walgreens, Wakefern, and Brookshire Grocery Co., further reinforcing its position as a protector of innovation in the retail sector.
Alpha Modus's strategic partnerships, including a recent agreement with CashXAI Inc., highlight the commercial viability and industry recognition of its patented solutions. These collaborations aim to deploy Alpha Modus's technologies across extensive retail networks, enhancing consumer engagement and driving measurable returns for retailers and brands.
Alpha Modus remains steadfast in its mission to develop and license data-driven technologies that enhance consumers' in-store digital experiences. Alpha Modus continues to explore strategic partnerships and licensing opportunities to expand the reach of its patented solutions.
For more information about Alpha Modus and its portfolio of innovations, please visit alphamodus.com.
About Alpha Modus
Alpha Modus is a technology company specializing in artificial intelligence solutions for the retail industry. Alpha Modus develops and licenses data-driven technologies that enhance consumer engagement and optimize in-store experiences. Headquartered in Cornelius, North Carolina, Alpha Modus is committed to leading the evolution of retail through innovation and strategic partnerships.
Forward-Looking Statements
This press release includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Alpha Modus's actual results may differ from their expectations, estimates, and projections, and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as 'expect,' 'estimate,' 'project,' 'budget,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'may,' 'will,' 'could,' 'should,' 'believes,' 'predicts,' 'potential,' 'continue,' and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements, but are not the exclusive means of identifying these statements. These forward-looking statements include, without limitation, Alpha Modus's expectations with respect to future performance.
Alpha Modus cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Alpha Modus does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
Contact Information
Investor Relations
Alpha Modus Holdings, Inc.
Email: [email protected]
Website: www.alphamodus.com
Follow us on LinkedIn | Follow us on X

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One
The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Yahoo

time22 minutes ago

  • Yahoo

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Omada Health (NASDAQ:OMDA) opened its first day of trading with a bangjumping 21% to $23 after pricing its IPO at $19. That move gives the digital chronic-care startup a market cap of roughly $1.3 billion. The $150 million raise was more than just well receivedinvestor demand came in more than 15x oversubscribed, with most allocations going to a concentrated group of institutional buyers. It's another sign that appetite for health-tech IPOs is heating up again. U.S. listings have raised nearly $25 billion year-to-date, and early-stage healthcare names are up an average of 18% since listing. Founded in 2011, Omada offers virtual care between doctor visitsfocused on diabetes, obesity, hypertension, and joint pain. What sets it apart? It's not chasing the GLP-1 gold rush. Instead, Omada supports people already on those drugs, helping them manage side effects, nutrition, and post-treatment maintenance. About 50,000 of its 679,000 members are on GLP-1s. CEO Sean Duffy told Bloomberg that while AI powers much of the back-end, real human interaction is what drives results. Our members tell us they want a personand I have yet to see anyone that feels accountable to ChatGPT, he said. Revenue for Q1 2025 came in just under $55 millionup from $35.1 million a year agowhile net losses narrowed by more than half to $9.4 million. That improving financial picture, combined with a clear niche in chronic care, could be what's drawing top-tier investors. Revelation Partners, Andreessen Horowitz, Fidelity, and USVP are all among the largest shareholders. The IPO was led by Morgan Stanley, Goldman Sachs, and JPMorgan. OMDA now trades on the Nasdaq Global Marketand it's one more sign that digital health might be staging a real comeback. This article first appeared on GuruFocus.

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO
Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Yahoo

time26 minutes ago

  • Yahoo

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Omada Health (OMDA, Financials) surged 42% in its Nasdaq debut Friday after the virtual chronic care company priced its initial public offering at $19 per share, raising $150 million and securing a valuation just above $1 billion. The stock opened at $23 and climbed quickly past $27. Warning! GuruFocus has detected 8 Warning Sign with X. Founded in 2012, Omada offers virtual programs for chronic conditions including prediabetes, diabetes, and hypertension. The IPO, which sold 7.9 million shares, is part of a recent resurgence in health and tech listings, following last month's debut of Hinge Health and Thursday's surge in Circle Internet shares. In its prospectus, Omada reported Q1 revenue jumped 57% year over year to $55 million, while full-year 2024 revenue rose 38% to $169.8 million. The company narrowed its net loss in the most recent quarter to $9.4 million from $19 million a year earlier. Major outside shareholders include U.S. Venture Partners, Andreessen Horowitz, and Fidelity's FMR LLC, each holding a 9% to 10% stake. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It
Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It

Yahoo

time26 minutes ago

  • Yahoo

Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It

Grab (NASDAQ:GRAB) is quietly pushing forward on what could be one of Southeast Asia's biggest tech shakeupsa $7 billion move to acquire rival GoTo. After years of circling each other, the two ride-hailing and food delivery giants are now refining a two-step deal: GoTo could first absorb Grab's Indonesia unit, then Grab would swoop in for control of the merged business. But it's not just about market strategy. The deal faces serious political and regulatory headwinds, especially in Indonesia, where a merger would concentrate 6070% of the on-demand market in one player's hands. Warning! GuruFocus has detected 5 Warning Sign with GRAB. Enter DanantaraIndonesia's sovereign wealth fundwhich has kicked off early-stage talks to buy a minority stake in the new entity. That move could help ease nationalist fears over foreign dominance, job losses, and rising consumer costs. For President Prabowo's government, which has been flexing its populist muscles with wage hikes, subsidy boosts, and demands for driver bonuses, having a local backer in the mix might be a political win. For Grab, it's a potential green light. But the clock is ticking. Any deal still hinges on clearance from Indonesia's antitrust watchdog, and regulatory nerves remain high. Meanwhile, the market dynamics are shifting fast. Grab's revenue in Indonesia rose just 6.3% in 2024its slowest in Southeast Asiawhile GoTo has already exited Vietnam and Thailand. A tie-up would give Grab more firepower in Indonesia's 275-million-strong market, just as newer players like InDrive and Maxim try to muscle in. The stakes? If Danantara comes onboard, the merger could reshape Southeast Asia's tech landscape. If not, Grab might have to find another way into the driver's seat. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store